Delivery Order 36F79724D0020-36C24924F0105

Award Date 4/1/24
Potential Completion Date 9/30/24
Potential Value Not listed
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Knoxville, TN 37919, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the Veterans Integrated Service Network 9 (VISN 9) to Biomerieux Inc. for the supply of BIOFIRE REAGENTS. The contract has a ceiling value of $122,266.60 and a period of performance through October 31, 2024. Biomerieux Inc., a global leader in in vitro diagnostics, will provide its proprietary diagnostic platforms, reagents, and test kits to support infectious disease testing and pathogen detection across VISN 9 healthcare operations....
This federal contract award was issued by the Veterans Integrated Service Network 9 (VISN 9), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at $155,093.48, was awarded to Biomerieux Inc. through its Biomerieux, Inc. division for the provision of BIOFIRE REAGENTS. The contract is a delivery order under the Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits, which allows various government agencies to procure Biomerieux's...
This federal contract award is for BIOFIRE REAGENTS, provided to the Veterans Integrated Service Network 9 (VISN 9) by Biomerieux Inc., through its Biomerieux, Inc. division. The contract is a firm-fixed-price Delivery Order with a ceiling value of $28,535.24 and a performance period ending on September 30, 2024. The contract is under the General Services Administration (GSA) Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits. Biomerieux Inc. is a global leader in...
This federal contract award is for the delivery of BIOFIRE REAGENTS to the Veterans Integrated Service Network 17 (VISN 17), which is a component of the Department of Veterans Affairs (VA). The contract was awarded to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. Division. The contract has a ceiling value of $51,455.24 and is a firm-fixed-price delivery order with an ultimate completion date of April 16, 2028. The contract does not have a set-aside...
This is a firm-fixed-price delivery order awarded by the Veterans Integrated Service Network 16 (VISN 16) to Biomerieux Inc., a global leader in in vitro diagnostics. The $989,765.95 contract is for the company's BIOFIRE diagnostic products and services, which includes automated microbial identification systems, antibiotic susceptibility testing platforms, and molecular diagnostic technologies. The contract is not set-aside and is placed under Biomerieux's existing Federal Supply Schedule...
This is a definitive contract awarded by the Department of Veterans Affairs (VA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of BIOFIRE REAGENTS AND WARRANTIES. The contract has a ceiling value of $14,074,676.68 and a period of performance ending on December 31, 2027. The contract is a firm fixed-price agreement, with no set-aside designation. Biomerieux Inc., doing business as Vitek Systems, Inc., has been established as a critical supplier of specialized...
The U.S. Department of Veterans Affairs, specifically the Veterans Integrated Service Network 17, awarded a delivery order contract to Biomerieux Inc. for the procurement of BIOFIRE CONSUMABLES. The firm-fixed-price contract has a ceiling value of $311,214.16 and a period of performance ending on September 14, 2024. The contract does not have a set-aside designation. Biomerieux Inc., a global leader in in vitro diagnostics, will provide its proprietary diagnostic platforms, reagents, and test...
This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the supply of BioFire consumables. The $1,201,831.64 firm-fixed-price contract was awarded by the Veterans Integrated Service Network 17 (VISN 17), a division of the Department of Veterans Affairs. The contract is a Blanket Purchase Agreement (BPA) call under Biomerieux's existing Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits. This contract does not involve any...
This firm-fixed-price delivery order was awarded to Biomerieux Inc., a global leader in in vitro diagnostics, by the Department of Veterans Affairs' Veterans Integrated Service Network 17. The $51,455.24 contract is for the procurement of BioFire reagents for the OP 2 (Operations 2) program and does not have a set-aside designation. Biomerieux Inc. holds several Indefinite Delivery Vehicles (IDVs) with the federal government, including a $194 million Federal Supply Schedule contract for In Vitro...
This federal contract award is for BIOFIRE REAGENTS and was awarded by the Veterans Integrated Service Network 9 (VISN 9) of the U.S. Department of Veterans Affairs. The contract has a ceiling value of $52,724.27 and a completion date of September 30, 2024. The contract was awarded to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. division doing business as Vitek Systems, Inc. The contract is a Delivery Order placed under the General Services...

This is a delivery order contract awarded by the Veterans Integrated Service Network 9 (VISN 9) to Biomerieux Inc. through its Biomerieux, Inc. division. The contract is for the procurement of BIOFIRE REAGENTS, which are used in in vitro diagnostic tests. The contract has a ceiling value of $19,027.50 and a period of performance ending on September 30, 2024. The contract is a firm-fixed-price delivery order under Biomerieux's existing Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. This allows various government agencies to efficiently order Biomerieux's specialized diagnostic products and services. The contract does not involve any set-aside designations, as Biomerieux is often the sole-source provider for its proprietary technologies. Biomerieux Inc. is a global leader in in vitro diagnostics, serving federal agencies such as the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services with its automated microbial identification systems, antibiotic susceptibility testing platforms, and molecular diagnostic technologies.

Generated 2/8/25, 9:14 AM